Top health officials urge Americans to get vaccinated but barely address the J.&J. dose pause.

Injections of the Johnson & Johnson coronavirus vaccine came to a sudden halt this week in the United States after a small number of rare blood clots emerged, though it is unclear if the shot was responsible.


Biden’s Afghan Pullout Is a Victory for Pakistan. But at What Cost?

Pakistan’s military stayed allied to both the Americans and Taliban. But now the country may face intensified extremism at home as a result of a perceived Taliban victory.


John Williamson, 83, Dies; Economist Defined the ‘Washington Consensus’

A careful pragmatist, he regretted the way his term, aimed at developing countries, was misinterpreted by free-market ideologues and anti-globalization activists.


Eritrean Troops Continue to Commit Atrocities in Tigray, U.N. Says

Despite a promise to leave, Eritrea’s troops remain in northern Ethiopia, aiding the Ethiopian government campaign there, a senior U.N. official told the Security Council.


Prince Philip’s Funeral Will Include a Call to Battle

The prince approved plans for his own funeral and, despite coronavirus restrictions, the ceremony will reflect his wishes, officials say.


Your Friday Briefing

Tough U.S. penalties for Russian hacking.


Biden Sanctions on Russian Debt Called a ‘First Salvo’ That Send a Message

The curbs on U.S. banks’ purchases of some bonds apply to a small portion of the market but could signal a sharper aim at Russia’s access to global capital.


White House Warns Russia on Bounties, but Stops Short of Sanctions

The available evidence supporting a stunning C.I.A. assessment — which President Donald J. Trump’s inaction on prompted bipartisan uproar — remains less than definitive proof.


France Lawmakers Pass Contentious Bill Extending Police Powers

The legislation was criticized by civil rights groups and political opponents, who intend to challenge its constitutionality.


Vaccines Won’t Protect Millions of Patients With Weakened Immune Systems

Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.